The science is real, the results are encouraging, and the risk profile is minimal a combination that's hard to beat
Wrote the paper: CC, LL, and KL
Nu Image Medical may not offer the medications or services mentioned in this article.
In contrast, DFP treatment significantly decreased Fe 2+ levels in optic nerve tissue, downregulated TFR1 and Iba-1 expression, and inhibited iron deposition, ferroptosis, microglial activation, and astrocyte proliferation, thereby reducing myelin loss and optic nerve damage in MS mice (Rayatpour et al., 2022)
Vitamin D, magnesium, and iron deficiencies are frequently documented in patients on long-term GLP-1 therapy